Bovex 2.265%

Држава: Ирска

Језик: Енглески

Извор: HPRA (Health Products Regulatory Authority)

Активни састојак:

Oxfendazole

Доступно од:

Chanelle Pharmaceuticals Manufacturing Limited

АТЦ код:

QP52AC02

INN (Међународно име):

Oxfendazole

Дозирање:

2.265 percent weight/volume

Фармацеутски облик:

Oral suspension

Тип рецептора:

POM: Prescription Only Medicine as defined in relevant national legislation

Терапеутска група:

Cattle, Sheep

Терапеутска област:

oxfendazole

Терапеутске индикације:

Endoparasiticide

Статус ауторизације:

Authorised

Датум одобрења:

1992-08-05

Карактеристике производа

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bovex 2.265%
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Oral suspension.
A cream coloured suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, Sheep
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Bovex 2.265% is a broad spectrum worm drench for cattle and sheep
indicated for the treatment and control of mature and
immature gastrointestinal roundworms, lungworms and tapeworms.
It is also ovicidal.
Bovex 2.265% is active against:-
ROUNDWORMS:
_Ostertagia_ spp,_ Haemonchus_ spp,_ Trichostrongylus_ spp,_
Nematodirus,_ (including_ N. battus_),_ Cooperia_
spp,_ Capillaria_ spp,_ Oesophagostomum_ spp,_ Chabertia_ spp, and_
Trichuris_ spp.
LUNGWORMS:
_Dictyocaulus_ spp,
TAPEWORMS:
_Moniezia_ spp.
It is also effective in the prevention and control of Type II
Ostertagiasis.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredient.
Active Substance
Oxfendazole
2.265 %w/v
Excipients
Methyl Parahydroxybenzoate (E218)
0.2
%w/v
Propyl Parahydroxybenzoate (E216)
0.02
%w/v
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_1_
_/_
_0_
_5_
_/_
_2_
_0_
_1_
_3_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_4_
_7_
_3_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care must be taken not to damage the pharyngeal region when dosing,
particularly in sheep.
As with other anthelmintics, veteri